Treatment patterns and appropriateness of antipsychotic prescriptions in patients with schizophrenia
- PMID: 34188093
- PMCID: PMC8241998
- DOI: 10.1038/s41598-021-92731-w
Treatment patterns and appropriateness of antipsychotic prescriptions in patients with schizophrenia
Erratum in
-
Author Correction: Treatment patterns and appropriateness of antipsychotic prescriptions in patients with schizophrenia.Sci Rep. 2024 Mar 1;14(1):5138. doi: 10.1038/s41598-024-55913-w. Sci Rep. 2024. PMID: 38429377 Free PMC article. No abstract available.
Abstract
Schizophrenia is a chronic mental condition presenting a wide range of symptoms. Although it has a low prevalence compared to other mental conditions, it has a negative impact on social and occupational functions. This study aimed to assess the appropriateness of antipsychotic medications administered to schizophrenic patients and describe current treatment patterns for schizophrenia. A retrospective cohort study was conducted in all patients over the age of 15 with an active diagnosis of schizophrenia and treated with antipsychotics between 2008 and 2013 in the Valencia region. A total of 19,718 patients were eligible for inclusion. The main outcome assessed was inappropriateness of the pharmacotherapeutic management, including polypharmacy use. Altogether, 30.4% of patients received antipsychotic polypharmacy, and 6.8% were prescribed three or more antipsychotics. Overdosage affected 318 individuals (1.6%), and 21.5% used concomitant psychotropics without an associated psychiatric diagnosis. Women and people with a comorbid condition like anxiety or depression were less likely to receive antipsychotic polypharmacy. In contrast, increased polypharmacy was associated with concomitant treatment with other psychoactive drugs, and only in user on maintenance therapy, with more visits to the mental health hospital. Overall, we observed a high level of inappropriateness in antipsychotic prescriptions. Greater adherence to guidelines could maximize the benefits of antipsychotic medications while minimizing risk of adverse effects.
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns.Psychiatr Serv. 2007 Apr;58(4):489-95. doi: 10.1176/ps.2007.58.4.489. Psychiatr Serv. 2007. PMID: 17412850 Free PMC article.
-
Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.Clin Ther. 2007 Jan;29(1):183-95. doi: 10.1016/j.clinthera.2007.01.002. Clin Ther. 2007. PMID: 17379060
-
[Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].Encephale. 2002 Mar-Apr;28(2):129-38. Encephale. 2002. PMID: 11972139 French.
-
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].Encephale. 2005 Mar-Apr;31(2):235-46. doi: 10.1016/s0013-7006(05)82390-5. Encephale. 2005. PMID: 15959450 Review. French.
-
Antipsychotic polypharmacy in schizophrenia: benefits and risks.CNS Drugs. 2011 May;25(5):383-99. doi: 10.2165/11587810-000000000-00000. CNS Drugs. 2011. PMID: 21476610 Review.
Cited by
-
Evaluation of Prescription Patterns of Antipsychotics in Schizophrenia Patients-A Single-Center Prospective Study.J Clin Med. 2025 Apr 24;14(9):2941. doi: 10.3390/jcm14092941. J Clin Med. 2025. PMID: 40363973 Free PMC article.
-
Global Neuropsychopharmacological Prescription Trends in Adults with Schizophrenia, Clinical Correlates and Implications for Practice: A Scoping Review.Brain Sci. 2023 Dec 20;14(1):6. doi: 10.3390/brainsci14010006. Brain Sci. 2023. PMID: 38275511 Free PMC article.
-
Efficacy and tolerability of pharmacological interventions for schizophrenia non-responsive to prior treatment: a systematic review and network meta-analysis.EClinicalMedicine. 2025 Jun 7;84:103291. doi: 10.1016/j.eclinm.2025.103291. eCollection 2025 Jun. EClinicalMedicine. 2025. PMID: 40535000 Free PMC article.
-
Tardive dyskinesia in Asia- current clinical practice and the role of neurologists in the care pathway.Front Neurol. 2024 Feb 14;15:1356761. doi: 10.3389/fneur.2024.1356761. eCollection 2024. Front Neurol. 2024. PMID: 38419696 Free PMC article.
-
Prescriptions of Antipsychotics in Younger and Older Geriatric Patients with Polypharmacy, Their Safety, and the Impact of a Pharmaceutical-Medical Dialogue on Antipsychotic Use.Biomedicines. 2022 Dec 4;10(12):3127. doi: 10.3390/biomedicines10123127. Biomedicines. 2022. PMID: 36551883 Free PMC article.
References
-
- World Health Organization (WHO). Schizophrenia. https://www.who.int/news-room/fact-sheets/detail/schizophrenia (2019).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical